F-star moves into new facility in Cambridge, UK F-star moves into new facility in Cambridge, UK Also expands team with appointment of Michael Davies as VP Protein Sciences Novavax makes management promotions Novavax makes management promotions Also appoints Bob Darius as SVP, Quality Operations Kymab appoints Dr David Chiswell as Chief Executive Kymab appoints Dr David Chiswell as Chief Executive Steps up from interim CEO of the Cambridge, UK-based firm Two new appointments at BASF in the UK & Ireland Two new appointments at BASF in the UK & Ireland Richard Carter and Darren Budd take on new roles at the chemicals giant New Chief Executive and Chairman for Asterias Biotherapeutics New Chief Executive and Chairman for Asterias Biotherapeutics Stephen Cartt and Don Bailey join the US biopharmaceutical firm Pherecydes Pharma appoints Guy-Charles Fanneau de La Horie as Chief Executive Pherecydes Pharma appoints Guy-Charles Fanneau de La Horie as Chief Executive He joins the firm to secure funding and further develop phage therapy to fight bacterial infections Ubiquigent strengthens team Ubiquigent strengthens team And enhances its drug discovery service capabilities Spero Therapeutics hires Cristina Larkin as Chief Commercial Officer Spero Therapeutics hires Cristina Larkin as Chief Commercial Officer Her expertise covers various infectious disease products Ideal Cures expands global reach with a presence in America Ideal Cures expands global reach with a presence in America Appoints Kamlesh Oza as President – Global Business Development New President of EMEA Operations for Astellas New President of EMEA Operations for Astellas Yukio Matsui will assume his new position on 1 April 2016 Medica Packaging appoints Jon Clark as Head of Procurement Medica Packaging appoints Jon Clark as Head of Procurement Clark has held a variety of procurement, commercial and operational roles within the packaging industry West Pharmaceutical Services promotes Eric Resnick to Chief Technology Officer West Pharmaceutical Services promotes Eric Resnick to Chief Technology Officer He succeeds John Paproski who is to retire after 36 years of service Brighton professor joins US organisation that supports research into ageing Brighton professor joins US organisation that supports research into ageing Professor Richard Faragher is elected to Board of Directors of the American Federation of Aging Research (AFAR) Validant expands senior leadership team Validant expands senior leadership team Linda Peters and Brian Burns join the regulatory services firm DBV Technologies welcomes Edward Jordan as SVP Commercial Operations North America DBV Technologies welcomes Edward Jordan as SVP Commercial Operations North America As the biopharmaceutical firm prepares for the commercialisation of products to treat food allergies Regional Sales Manager for France joins Microscan Regional Sales Manager for France joins Microscan Nicolas Rozencwajg brings more than 20 years of relevant experience to the position Astellas promotes Catherine Wertjes to Head of Ethics & Compliance Astellas promotes Catherine Wertjes to Head of Ethics & Compliance Catherine Levitt assumes Wertjes' previous role as VP, Legal for Astellas US Stefan Rampf to take over as CFO at Rentschler on 1 May Stefan Rampf to take over as CFO at Rentschler on 1 May He will be responsible for commercial management Neuralstem appoints Richard Daly as President and Chief Executive Neuralstem appoints Richard Daly as President and Chief Executive He succeeds co-founder Richard Garr J. Michael Pearson returns as CEO of Valeant following illness J. Michael Pearson returns as CEO of Valeant following illness Robert A. Ingram appointed Chairman of the Board as the roles of Chairman and CEO are separated French biopharmaceutical firm Pharnext hires two French biopharmaceutical firm Pharnext hires two Niall Murphy as Chief Scientific Officer and Pierre Schwich as Chief Financial Officer Werner Baumann to succeed Marijn Dekkers as Chairman of Bayer's Board of Management Werner Baumann to succeed Marijn Dekkers as Chairman of Bayer's Board of Management He will take up the role on 1 May 2016 Intarcia Therapeutics appoints Head of Global Medical Affairs, Safety and Operations Intarcia Therapeutics appoints Head of Global Medical Affairs, Safety and Operations John Yee takes the newly created position at the US biopharmaceutical firm Mylan CEO Heather Bresch elected Chair of Generic Pharmaceutical Association Mylan CEO Heather Bresch elected Chair of Generic Pharmaceutical Association She will hold this position for one year